PEPSICO® ANNOUNCES LANDMARK GLOBAL PARTNERSHIP WITH MERCEDES-AMG PETRONAS F1 TEAM FOR 2026
Gatorade®, Sting®, and Doritos® unite performance, energy, and flavor with the eight-time FIA World Constructors' Champions PURCHASE, N.Y., Dec. 2, 2025 /PRNewswire/ -- Today, PepsiCo announces a landmark global partnership with Mercedes-AMG...
Antengene Announces IND Approval in China for Phase Ib/II Study of ATG-022 (CLDN18.2 ADC) in Combination with KEYTRUDA® (Pembrolizumab) ± Chemotherapy
SHANGHAI and HONG KONG, Dec. 2, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class...
Accord Healthcare Announces Launch of Denosumab∇ - Second Biosimilar in Bone Health
∇ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. LONDON, Dec. 2, 2025 /PRNewswire/ -- Accord Healthcare today announced the launch of Osvyrti (denosumab), a biosimilar to Prolia®...
ZAGENO Receives Frost & Sullivan's 2025 Global Company of the Year Recognition for Excellence in Life Sciences E-commerce Leadership
ZAGENO earns global recognition for driving innovation, operational efficiency, and transformative customer value across the life sciences e-commerce ecosystem. SAN ANTONIO, Dec. 2, 2025 /PRNewswire/ -- Frost & Sullivan is pleased to announce...
Automic Group Announces Senior Executive Leadership Appointments to Drive Growth and Innovation Agenda
SYDNEY, Dec. 2, 2025 /PRNewswire/ -- Automic Group, Australia's market leader in technology-driven investor administration and services, announces two senior executive appointments to drive further growth and accelerate the Group's strategy. Stacey...
Lynk Pharmaceuticals Announces FDA IND Approval of Its Allosteric TYK2 Inhibitor LNK01006
HANGZHOU, China and SHANGHAI and BOSTON, Dec. 2, 2025 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on developing innovative therapies...
CQ Medical® Expands Radiation Therapy Portfolio With Bionix Business Unit Acquisition
AVONDALE, Pa., Dec. 2, 2025 /PRNewswire/ -- CQ Medical, the global leader in patient radiotherapy positioning and healthcare innovation, is proud to announce the acquisition of Bionix's Radiation Therapy business unit, marking an expansion of its...
First Participating Phygital Stars for the Games of the Future 2025 in Abu Dhabi Announced
Elite clubs and phygital athletes from around the world confirmed to compete at the pinnacle phygital event for a multi-million-dollar prize pool up for grabs DUBAI, UAE, Dec. 1, 2025 /PRNewswire/ -- Phygital International today announces the first...
YOULIFE ANNOUNCES CHANGES IN BOARD OF DIRECTORS AND MANAGEMENT
BEIJING, Dec. 1, 2025 /PRNewswire/ -- Youlife Group Inc. (Nasdaq: YOUL, "Youlife" or the "Company"), a leading blue-collar lifetime service provider in China, today announced changes in its board of directors (the "Board") and management. Changes in...
CN Energy Group. Inc. Announces Launch of PATHENBOT Robotics Solutions Platform and PATHENBOT's Official Website
LISHUI, China, Dec. 1, 2025 /PRNewswire/ -- CN Energy Group. Inc. ("CNEY" or the "Company") (NASDAQ: CNEY), a Nasdaq-listed company, today announced that its wholly owned subsidiary, PATHENBOT Group Inc. ("PATHENBOT"), has launched its robotics...